Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells

BACKGROUND: Autologous hematopoietic progenitor cell (HPC) transplantation is currently the standard of care for a fraction of patients with newly diagnosed myelomas and relapsed or refractory lymphomas. After high-dose chemotherapy, cryopreserved HPC are either infused directly after bedside thawin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mfarrej, Bechara, Vicari, Olivier, Ouffai, Sarah, Malenfant, Carine, Granata, Angela, Thevenet, Sophie, Chabannon, Christian, Lemarié, Claude, Calmels, Boris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632571/
https://www.ncbi.nlm.nih.gov/pubmed/36329460
http://dx.doi.org/10.1186/s12967-022-03703-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632571/
https://www.ncbi.nlm.nih.gov/pubmed/36329460
http://dx.doi.org/10.1186/s12967-022-03703-1

Ejemplares similares